Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 693 citations

Medicine, Genetics, Molecular Genetics +10

Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

Eli L. Diamond, Lorenzo Dagna, David M. Hyman et al. · Blood · 2014 · 586 citations · Full text

Medicine, Pathology, Pulmonology +3

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 530 citations

Medicine, Molecular Biology, Molecular Genetics +10

Langerhans'-cell histiocytosis in adults

Iris Baumgärtner, A. von Hochstetter, Brigitta G. Baumert et al. · Medical and Pediatric Oncology · 1997 · 321 citations

Medicine, Pathology, Histology +15

Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With <i>BRAF^V600E</i>-Mutated Erdheim-Chester Disease

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Journal of Clinical Oncology · 2014 · 287 citations

Medicine, Oncology, Pharmacotherapy +13